Results for 'universal drug insurance'

978 found
Order:
  1.  23
    Near equality in quality for medication utilization among older adults with diabetes with universal medication insurance in Ontario, Canada.Baiju R. Shah, Gillian L. Booth, Lorraine L. Lipscombe, Denice S. Feig, Onil K. Bhattacharyya & Arlene S. Bierman - 2014 - Journal of Evaluation in Clinical Practice 20 (2):176-183.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  2.  93
    Extraordinary Pricing of Orphan Drugs: Is it a Socially Responsible Strategy for the U.S. Pharmaceutical Industry? [REVIEW]Thomas A. Hemphill - 2010 - Journal of Business Ethics 94 (2):225 - 242.
    The PRIME Institute of the College of Pharmacy, University of Minnesota, recently released preliminary research findings indicating a trend of extraordinary pharmaceutical industry pricing of drug products in the United States (U.S.). According to researchers at the PRIME Institute, such extraordinary price increases are defined as any price increase that is equal to, or greater than, 100% at a single point in time. In some instances, PRIME Institute researchers found that drugs exhibiting extraordinary price increases are categorized as "orphan (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  3.  13
    Toward a Feminist History of the Drug-Using Woman—and Her Recovery.Trysh Travis - 2019 - Feminist Studies 45 (1):209-233.
    In lieu of an abstract, here is a brief excerpt of the content:Feminist Studies 45, no. 1. © 2019 by Feminist Studies, Inc. 209 Trysh Travis Toward a Feminist History of the Drug-Using Woman— and Her Recovery In 1995, public health scholars Laura Schmidt and Constance Weisner published “The Emergence of Problem-Drinking Women as a Special Population in Need of Treatment.”1 The article, aimed at specialists in the growing field of behavioral sciences, explored the history of medpsych attitudes toward (...)
    No categories
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  4.  36
    Corpus Interruptus: Biotech Drugs, Insurance Providers and the Treatment of Breast Cancer.Jane E. Schultz - 2007 - Journal of Bioethical Inquiry 4 (2):93-102.
    In researching the biomedically-engineered drug Neulasta, a breast cancer patient becomes aware of the extent to which knowledge about the development and marketing of drugs influences her decisions with regard to treatment. Time spent on understanding the commercial interests of insurers and pharmaceutical companies initially thwarts but ultimately aids the healing process. This first-person narrative calls for physicians to recognize that the alignment of commercial interests transgresses the patient’s humanity.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  5.  18
    The Ethics of Universal Health Insurance.Alex Rajczi - 2019 - New York, USA: Oxford University Press.
    In The Ethics of Universal Health Insurance, Alex Rajczi shows how defenders of universal health insurance can address the ethical issues raised by these objections and make the moral case for an American universal health insurance system that improves on the gains made in the Affordable Care Act.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  6.  26
    Universal Health Insurance: will it control the cost of U.S. health care?William P. Gunnar - 2008 - Perspectives in Biology and Medicine 51 (2):285-291.
  7.  35
    Corpus interruptus: Biotech drugs, insurance providers and the treatment of breast cancer. [REVIEW]Jane E. Schultz - 2007 - Journal of Bioethical Inquiry 4 (2):103-103.
    In researching the biomedically-engineered drug Neulasta (filgrastim), a breast cancer patient becomes aware of the extent to which knowledge about the development and marketing of drugs influences her decisions with regard to treatment. Time spent on understanding the commercial interests of insurers and pharmaceutical companies initially thwarts but ultimately aids the healing process. This first-person narrative calls for physicians to recognize that the alignment of commercial interests transgresses the patient’s humanity.
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  8.  36
    The Universal Drug Testing of Employees.Douglas Birsch - 1995 - Business and Professional Ethics Journal 14 (3):43-59.
  9.  49
    Research Ethics Committee Auditing: The Experience of a University Hospital. [REVIEW]Daniela Marchetti, Angelico Spagnolo, Marina Cicerone, Fidelia Cascini, Giuseppe La Monaca & Antonio G. Spagnolo - 2013 - HEC Forum 25 (3):257-268.
    The authors report the first Italian experience of a research ethics committee (REC) audit focused on the evaluation of the REC’s compliance with standard operating procedures, requirements in insurance coverage, informed consent, protection of privacy and confidentiality, predictable risks/harms, selection of subjects, withdrawal criteria and other issues, such as advertisement details and justification of placebo. The internal audit was conducted over a two-year period (March 2009–February 2011) divided into quarters to better value the influence of the new insurance (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark  
  10.  14
    Making Universal Health Insurance Work in Massachusetts.Alan Sager - 1989 - Journal of Law, Medicine and Ethics 17 (3):269-282.
  11.  5
    Making Universal Health Insurance Work in Massachusetts.Alan Sager - 1989 - Journal of Law, Medicine and Ethics 17 (3):269-282.
    Direct download  
     
    Export citation  
     
    Bookmark  
  12.  28
    The Ethics of Universal Health Insurance, by Alex Rajczi. New York: Oxford University Press, 2019. 352 pp. [REVIEW]Jeffery Smith - 2020 - Business Ethics Quarterly 30 (1):164-167.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  13.  43
    Conflict and Compromise Over Tradeoffs in Universal Health Insurance Plans.Mark V. Pauly - 2004 - Journal of Law, Medicine and Ethics 32 (3):465-473.
    Despite a consensus across the political spectrum that the problem of the chronically uninsured is in dire need of solution, little progress has been made. Public spending goes to topping up coverage for the elderly, already heavily subsidized under Medicare, or helping people temporarily without insurance because of international trade dislocations, so that it is clear that something is lacking in the case for significantly reducing the number of uninsured persons. In this paper I suggest that there have been (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  14.  22
    Conflict and Compromise over Tradeoffs in Universal Health Insurance Plans.Mark V. Pauly - 2004 - Journal of Law, Medicine and Ethics 32 (3):465-473.
    Despite a consensus across the political spectrum that the problem of the chronically uninsured is in dire need of solution, little progress has heen made. Public spending goes to topping up coverage for the elderly, already heavily subsidized under Medicare, or helping people temporarily without insurance because of international trade dislocations, so that it is clear that something is lacking in the case for significantly reducing the number of uninsured persons. In this paper I suggest that there have been (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  15.  24
    After Insurance Reform: An Adequate Safety Net Can Bring Us to Universal Coverage.Mark A. Hall - 2009 - Hastings Center Report 39 (6):9-10.
    The overriding goal of health reform is to provide every American affordable access to adequate health care. Yet in every national effort to date, the focal means to this end has always been health insurance. Massachusetts is congratulated for having achieved nearly universal insurance coverage, and congressional Democrats are aiming for the same. But what if they don't succeed? Even in Massachusetts, 167,000 residents remain uninsured. Is it still possible to provide adequate access to medical care for (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  16.  12
    Psychonauts: Drugs and the Making of the Modern Mind, by Mike Jay. New Haven, CT: Yale University Press, 2023.Erika Dyck - 2024 - Journal of Medical Humanities 45 (1):125-126.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  17.  11
    Drug abuse and drug addiction among students of University of Rajshahi.Faiqua Tahjiba - 2020 - Bangladesh Journal of Bioethics 11 (3):21-32.
    Objectives: The aim of this study was to investigate the actual condition of the students of University of Rajshahi (RU) regarding drug abuse and addiction. Using case study method the research was conducted with four objectives: (a) to find out how respondents began drug abuse; (b) to discover the causes of their drug addiction; (c) to understand the process of their drug abuse; and (d) to find out the economic, social and health effects of drug (...)
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  18.  8
    Students’ perspectives on drugs and alcohol abuse at a public university in Zambia.Nicholas Mwanza & Ganizani Mwale - 2023 - HTS Theological Studies 79 (3):8.
    Access to students’ perspectives on substance abuse is essential for effective youth intervention projects development. This study aimed to explore students’ perspectives on abuse of drugs and alcohol with probable development of student-led intervention strategies. The study was conducted at public universities in Zambia. Student’s perspectives on drugs and alcohol abuse were documented using a mixed method design that employed purposive and snowball sampling to select 200 respondents to questionnaires and 10 to in-depth interviews. A humanistic theory approach was applied (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  19.  13
    Drugs on the Page: Pharmacopoeias and Healing Knowledge in the Early Modern Atlantic World: edited by M. J. Crawford and J. M. Gabriel, Pittsburgh: Pittsburgh University Press, 2019, ix+374 pp., $50.00, ISBN 0-822-94562-2.Katrina Maydom - 2021 - Annals of Science 78 (2):259-261.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  20.  33
    Drugs, the Nation and Free Lancing: Decoding the Moral Universe of William Bennett.William E. Connolly - 1991 - Theory and Event 1 (1).
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  21.  6
    Drugs Politics: Managing Disorder in the Islamic Republic of Iran. By MaziyarGhiabi. Pp. xix, 343, Cambridge University Press, 2019, $78.57. [REVIEW]Richard Penaskovic - 2021 - Heythrop Journal 62 (1):179-179.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  22.  12
    The poison trials: wonder drugs, experiment, and the battle for authority in renaissance science: by Alisha Rankin, Chicago and London, University of Chicago Press, 2021, 312 pp., 34 fig., 1 table, $35 (Paper), ISBN 978-0-226-74485-8.Georgiana D. Hedesan - 2022 - Annals of Science 79 (3):408-410.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  23.  75
    Reassessing insurers' access to genetic information: Genetic privacy, ignorance, and injustice.Eli Feiring - 2008 - Bioethics 23 (5):300-310.
    Many countries have imposed strict regulations on the genetic information to which insurers have access. Commentators have warned against the emerging body of legislation for different reasons. This paper demonstrates that, when confronted with the argument that genetic information should be available to insurers for health insurance underwriting purposes, one should avoid appeals to rights of genetic privacy and genetic ignorance. The principle of equality of opportunity may nevertheless warrant restrictions. A choice-based account of this principle implies that it (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  24.  33
    Self-interest and universal health care: why well-insured Americans should support coverage for everyone. [REVIEW]N. R. Hicks - 1995 - Journal of Medical Ethics 21 (5):317-317.
    Direct download (8 more)  
     
    Export citation  
     
    Bookmark  
  25. Hypothetical Insurance and Higher Education.Ben Colburn & Hugh Lazenby - 2016 - Journal of Philosophy of Education 50 (4):587-604.
    What level of government subsidy of higher education is justified, in what form, and for what reasons? We answer these questions by applying the hypothetical insurance approach, originally developed by Ronald Dworkin in his work on distributive justice. On this approach, when asking how to fund and deliver public services in a particular domain, we should seek to model what would be the outcome of a hypothetical insurance market: we stipulate that participants lack knowledge about their specific resources (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  26.  50
    Percepção, identificação e comportamento dos professores da ULBRA/Canoas frente ao uso de drogas na universidade; The ULBRA professors perception of drug abuse at the university.Adria Daniel, Carmen Freitas, José Vicente Lima Robaina, Lauraci Dondé da Silva, Loreci Menna Barreto & Lúcia Zelinda Zanella Felizardo - 2001 - Aletheia: An International Journal of Philosophy 13:53-61.
    Direct download  
     
    Export citation  
     
    Bookmark  
  27.  8
    Ethical Consideration of National Health Insurance Reform for Universal Health Coverage in the Republic of Korea.Yuri Lee, Siwoo Kim, So Yoon Kim & Ganglip Kim - 2019 - Asian Bioethics Review 11 (1):41-56.
    In the current era of the Sustainable Development Goals, many countries are attempting to strengthen their health system and achieving Universal Health Coverage. The Korean National Health Insurance system functions as a core element of health financing, contributing to achieving UHC by promoting public health and social security through insurance benefits for prevention, diagnosis, treatment, rehabilitation, childbirth, and health promotion. The Republic of Korea achieved 100% NHI coverage of the target population in 1989, 12 years after the (...)
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  28.  9
    The poison trials: wonder drugs, experiment, and the battle for authority in renaissance science: by Alisha Rankin, Chicago and London, University of Chicago Press, 2021, 312 pp., 34 fig., 1 table, $35 (Paper), ISBN 978-0-226-74485-8. [REVIEW]Georgiana D. Hedesan - 2022 - Annals of Science 79 (3):408-410.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  29.  33
    Bad Medicine. The Prescription Drug Industry in the Third World. M. Silverman, M. Lydecker, Ph. R. Lee. Stanford, California: Stanford University Press, 1992, ISBN 0-8047-1669-. [REVIEW]Klaus M. Leisinger - 1993 - Cambridge Quarterly of Healthcare Ethics 2 (3):388.
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark  
  30.  9
    The need for Hispanic cultural competency in drug abuse treatment training programs: An empirical and ethical evaluation of US universities.Veronica Fish - forthcoming - Clinical Ethics.
    Ethical clinical practice requires cultural competency. In the United States, Hispanics report stronger attitudinal barriers to drug abuse treatment than any other racial/ethnic group. Hispanics report feeling that drug abuse treatment providers do not understand their unique cultural needs and are unfamiliar with their experiences of discrimination and immigration. Using this case study to explore broader ethical and policy issues, this study investigates the extent to which US universities train counselors to address the culturally specific needs of Hispanic (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  31.  70
    Developing Drugs for the Developing World: An Economic, Legal, Moral, and Political Dilemma.David B. Resnik - 2001 - Developing World Bioethics 1 (1):11-32.
    This paper discusses the economic, legal, moral, and political difficulties in developing drugs for the developing world. It argues that large, global pharmaceutical companies have social responsibilities to the developing world, and that they may exercise these responsibilities by investing in research and development related to diseases that affect developing nations, offering discounts on drug prices, and initiating drug giveaways. However, these social responsibilities are not absolute requirements and may be balanced against other obligations and commitments in light (...)
    Direct download  
     
    Export citation  
     
    Bookmark   26 citations  
  32.  8
    Mexico’s Illicit Drug Networks and the State Reaction. By Nathan P.Jones. Pp. xiv, 194, Washington, D.C., Georgetown University Press, 2016, £17.77. [REVIEW]Patrick Madigan - 2019 - Heythrop Journal 60 (6):932-932.
  33.  5
    Arabian Drugs in Early Medieval Mediterranean Medicine. By Zohar Amar and Efraim Lev.Anya King - 2021 - Journal of the American Oriental Society 139 (1).
    Arabian Drugs in Early Medieval Mediterranean Medicine. By Zohar Amar and Efraim Lev. Edinburgh Studies in Classical Islamic History and Culture. Edinburgh: Edinburgh University Press, 2017. Pp. xiv + 290, ills. $125, £80.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  34.  6
    Generic Drug Policy and Suboxone to Treat Opioid Use Disorder.Rebecca L. Haffajee & Richard G. Frank - 2019 - Journal of Law, Medicine and Ethics 47 (S4):43-53.
    Despite some improvements in access to evidence-based medications for opioid use disorder, treatment rates remain low at under a quarter of those with need. High costs for brand name products in these medication markets have limited the volume of drugs purchased, particularly through public health insurance and grant programs. Brand firm anti-competitive practices around the leading buprenorphine product Suboxone — including product hops, citizen petitions and Risk Evaluation and Mitigation Strategy abuses — helped to maintain high prices by extending (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  35.  10
    Drugs and Justice: Seeking a Consistent, Coherent, Comprehensive View.Margaret P. Battin, Erik Luna, Arthur G. Lipman, Paul M. Gahlinger, Douglas E. Rollins, Jeanette C. Roberts & Troy L. Booher - 2008 - Oup Usa.
    This compact and innovative book tackles one of the central issues in drug policy: the lack of a coherent conceptual structure for thinking about drugs. Drugs generally fall into one of seven categories: prescription, over the counter, alternative medicine, common-use drugs like alcohol, tobacco and caffeine; religious-use, sports enhancement; and of course illegal street drugs like cocaine and marijuana. Our thinking and policies varies wildly from one to the other, with inconsistencies that derive more from cultural and social values (...)
    Direct download  
     
    Export citation  
     
    Bookmark   1 citation  
  36.  10
    Cash, credit and drugs: Zack Dorner: Merchants of medicines: the commerce and coercion of health in Britain’s long eighteenth century. Chicago: University of Chicago Press, 2020, 280 pp, $50 HB. [REVIEW]Pratik Chakrabarti - 2021 - Metascience 31 (1):61-63.
    No categories
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  37.  36
    Joseph Dumit. Drugs for Life: How Pharmaceutical Companies Define Our Health. xii + 262 pp., illus., tables, bibl., index. Durham, N.C./London: Duke University Press, 2012. $84.95 ; $23.95. [REVIEW]Robert Cooter - 2013 - Isis 104 (3):645-646.
  38.  34
    The Ethics of Insurance Industry Step Therapy Policies.Michael A. Santoro - 2019 - Business and Professional Ethics Journal 38 (3):339-351.
    Step therapy is an insurance company policy whereby patients must try a less costly treatment and fail-first before the insurer will cover another, more costly treatment. This article argues that there are relevant and well-established principles of medical ethics—the duty to practice evidenced-based medicine and the duty to consider cost-effectiveness when treating patients—that constrain and guide physician behavior with respect to step therapy; clinical practice guidelines promulgated by authoritative physician groups attempt to incorporate and reconcile the competing demands of (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  39.  44
    Drugs can be used to treat more than disease.Nick Bostrom - manuscript
    Future of Humanity Institute, James Martin 21st Century School, University of Oxford, Littlegate House, 16/17 St Ebbe's Street, Oxford OX1 1PT, UK; www.nickbostrom.com..
    Direct download  
     
    Export citation  
     
    Bookmark   4 citations  
  40.  23
    Medical insurance payments and patients involved in research.Angela R. Holder - 1993 - IRB: Ethics & Human Research 16 (1-2):19-22.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  41.  10
    Wigwam Tonic and Other Medicines: Matthew James Crawford and Joseph M. Gabriel (Eds): Drugs on the Page: Pharmacopoeias and Healing Knowledge in the Early Modern Atlantic World. University of Pittsburgh Press, Pittsburgh, 2019, 374 pp, $50.00 HB.Jonathan Simon - 2020 - Metascience 29 (2):221-224.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  42.  8
    School Well-Being and Drug Use in Adolescence.Rosa Santibáñez, Josu Solabarrieta & Marta Ruiz-Narezo - 2020 - Frontiers in Psychology 11:542126.
    This research is part of the last study Drugs and School IX developed in the Basque Country (Spain) by the Instituto Deusto de Drogodependencias (Deusto Institute of Drug Addiction) of the University of Deusto and the data gathered by means of cluster sampling in two stages. The sample is made up of N= 6.007 girls and boys ranging from 12 to 22 years of age in Secondary Education and the aim is to answer the following new research questions based (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  43.  23
    Edited by Matthew James Crawford, Joseph M. Gabriel. Drugs on the page: Pharmacopoeias and healing knowledge in the early modern Atlantic world. Pittsburgh, PA: University of Pittsburgh Press, 2019. ix + 384 pp. ISBN: 9780822945628. [REVIEW]Miruna Achim - 2020 - Centaurus 62 (4):839-841.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  44.  16
    David Patrick Keys;, John F. Galliher. Confronting the Drug Control Establishment: Alfred Lindesmith as a Public Intellectual. x + 235 pp., illus., figs., apps., bibls., indexes. Albany: State University of New York Press, 2000. $57.50 ; $18.95. [REVIEW]Caroline Jean Acker - 2002 - Isis 93 (2):337-338.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  45.  17
    Patient, heal thyself: how the new medicine puts the patient in charge.Robert M. Veatch - 2009 - New York: Oxford University Press.
    The puzzling case of the broken arm -- Hernias, diets, and drugs -- Why physicians cannot know what will benefit patients -- Sacrificing patient benefit to protect patient rights -- Societal interests and duties to others -- The new, limited, twenty-first-century role for physicians as patient assistants -- Abandoning modern medical concepts: doctor's "orders" and hospital "discharge" -- Medicine can't "indicate": so why do we talk that way? --"Treatments of choice" and "medical necessity": who is fooling whom? -- Abandoning informed (...)
    Direct download  
     
    Export citation  
     
    Bookmark   10 citations  
  46.  47
    Dealing Drugs with the Bush.Rachel A. Ankeny - 2004 - Cambridge Quarterly of Healthcare Ethics 13 (3):241-244.
    The past year in bioethics in Australia has been relatively predictable. We continue to struggle with rising healthcare costs, though thankfully not on par with numerous other countries due to a relatively positive economic outlook. We are still fighting difficulties associated with higher medical indemnity costs, which have again caused many physicians to leave private practice, particularly in high-risk and specialty practice areas. In response, the federal government delayed the imposition of the medical indemnity levy for physicians until mid 2005. (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark  
  47.  3
    Analyzing and labeling evolution in modern drug therapy: Jeremy Greene, Flurin Condrau, and Elizabeth Watkins (eds): Therapeutic revolutions: pharmaceuticals and social change in the twentieth century. Chicago: University of Chicago Press, 2016, 321 pp, $40.00 PB.John P. Swann - 2021 - Metascience 30 (1):45-48.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  48.  3
    Richard DeGrandpre. The Cult of Pharmacology: How America Became the World’s Most Troubled Drug Culture. x + 294 pp., apps., bibl., index. Durham, N.C.: Duke University Press, 2006. $24.95. [REVIEW]Erika Dyck - 2007 - Isis 98 (4):866-867.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  49. This section is an account of the responses toal975 questionnaire submitted to the presidents of500 of the largest US corporations about matters ranging from stealing an otherwise unobtainable drug to save one's son to whistle-blowing and bribery. The section also includes the comments of four university professors whose fields of study include ethics. As a whole, it provides an idea of the matters of moral concern among business executives and business ethics practitioners in the mid-1970s. [REVIEW]Moral Dilemmas - 1989 - In A. Pablo Iannone (ed.), Contemporary Moral Controversies in Business. Oxford University Press. pp. 61.
     
    Export citation  
     
    Bookmark  
  50. Drugs and the Problem of Law Abuse.D. G. Brown - 1972 - University of British Columbia Law Review 7 (1):1-16.
1 — 50 / 978